Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 62,684,642
- Share change
- +2,045,850
- Total reported value
- $194,353,719
- Price per share
- $3.10
- Number of holders
- 41
- Value change
- +$5,918,047
- Number of buys
- 15
- Number of sells
- 12
Report period
Q4 2022
Institutions
41
Top holders
10
CNTA full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
13%
|
19,963,157
|
$80,252,000 | — | 30 Sep 2022 | |
| Index Venture Life Associates VI Ltd |
13F
|
Company |
6.5%
|
9,961,789
|
$40,046,000 | — | 30 Sep 2022 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
6.3%
|
9,681,818
|
$38,921,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
4.5%
|
6,894,345
|
$27,715,000 | — | 30 Sep 2022 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
2.6%
|
3,931,818
|
$15,805,000 | — | 30 Sep 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.1%
|
3,236,352
|
$13,010,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
2,944,956
|
$11,787,000 | — | 30 Sep 2022 | |
| OUP Management Co., LLC |
13F
|
Company |
1.9%
|
2,937,615
|
$11,809,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
2,445,983
|
$9,833,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.3%
|
1,972,728
|
$7,930,000 | — | 30 Sep 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.1%
|
1,693,736
|
$6,809,000 | — | 30 Sep 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
0.81%
|
1,251,137
|
$5,030,000 | — | 30 Sep 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.54%
|
832,932
|
$3,348,000 | — | 30 Sep 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.47%
|
731,521
|
$2,941,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.46%
|
708,791
|
$2,849,000 | — | 30 Sep 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.33%
|
515,746
|
$2,073,000 | — | 30 Sep 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.26%
|
399,801
|
$1,607,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.19%
|
293,511
|
$1,180,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.16%
|
248,228
|
$998,000 | — | 30 Sep 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.16%
|
242,517
|
$975,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
225,368
|
$906,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.12%
|
178,568
|
$718,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.08%
|
117,800
|
$474,000 | — | 30 Sep 2022 | |
| Oasis Management Co Ltd. |
13F
|
Company |
0.07%
|
110,000
|
$442,000 | — | 30 Sep 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
82,055
|
$349,000 | — | 30 Sep 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.04%
|
57,421
|
$244,039 | — | 30 Sep 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
51,503
|
$207,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
29,911
|
$120,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
16,529
|
$66,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
16,494
|
$67,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
13,428
|
$53,000 | — | 30 Sep 2022 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0%
|
5,820
|
$23,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,277
|
$21,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,391
|
$14,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,885
|
$7,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,558
|
$6,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Sep 2022 | |
| ADIRONDACK TRUST CO |
13F
|
Company |
0%
|
925
|
$4,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
668
|
$3,000 | — | 30 Sep 2022 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0%
|
481
|
$2,000 | — | 30 Sep 2022 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
350
|
$1,000 | — | 30 Sep 2022 | |
| Crewe Advisors LLC |
13F
|
Company |
0%
|
220
|
$1,000 | — | 30 Sep 2022 | |
| INDEX VENTURES LIFE VI (JERSEY) L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
149,421
|
$1,189,391 | — | 27 May 2021 | |
| Francesco de Rubertis |
3/4/5
|
Director |
—
class O/S missing
|
281,162
|
$2,238,050 | — | 21 Mar 2022 | |
| Javad Shahidi |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
158,932
|
$1,265,099 | — | 30 Sep 2022 | |
| Aaron Kantoff |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
$477,600 | — | 18 Nov 2021 | |
| Marella Thorell |
3/4/5
|
Chief Accounting Officer |
—
class O/S missing
|
53,101
|
$422,684 | — | 21 Mar 2022 |
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) as of Q4 2022
As of 31 Dec 2022,
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,684,642 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, GENERAL ATLANTIC, L.P., BVF INC/IL, EcoR1 Capital, LLC, Vida Ventures Advisors, LLC, OUP Management Co., LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, Tanager Wealth Management LLP, and Samsara BioCapital, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
41
Q4 2022 holders
41
Holder diff
0
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.